Lobbying

Cabaletta Bio CABA's latest lobbying report covers Q4 2025, at under $5,000. Its first report covers Q1 2025; the issues it reports most are Medicare/Medicaid.

Cabaletta BioCABA

Cabaletta Bio stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2025
The first quarter a report named it

Lobbying by quarter

Cabaletta Bio lobbying by quarter
Cabaletta Bio lobbying by quarter
QuarterAmountReports
Q1 2025$30K1
Q2 2025$20K1
Q3 2025$01
Q4 2025$01
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Medicare and Medicaid$50K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports

Firms it paid

Firm
Hogan Lovells Cadwalader US$50K4 quarters

Former officials lobbying for it

Former position
ADAM J. FRIDMANCounsel for O&I, Comm. Foreign Affairs, 2013-2015; Staff Counsel, Comm. on Foreign Affairs, 2011-2013; Legal Fellow, Comm. on Foreign Affairs, 2010Q2 2025
CYBIL G. ROEHRENBECKLegislative Counsel to Office of Representative Walter B. Jones (2006 - 2010); Office of Representative J.C. Watts (2002)Q2 2025

Lobbying reports

Filed by
01/20for Q4 2025Hogan Lovells Cadwalader USUnder $5,000
25/10/16for Q3 2025Hogan Lovells Cadwalader USUnder $5,000
25/07/16for Q2 2025Hogan Lovells Cadwalader US$20K
25/04/21for Q1 2025Hogan Lovells Cadwalader US$30K
25/04/10for Q1 2025Hogan Lovells Cadwalader USUnder $5,000